Research Articles
Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
Bora Gurel, M. Scott Lucia, Ian M. Thompson Jr, Phyllis J. Goodman, Catherine M. Tangen, Alan R. Kristal, Howard L. Parnes, Ashraful Hoque, Scott M. Lippman, Siobhan Sutcliffe, Sarah B. Peskoe, Charles G. Drake, William G. Nelson, Angelo M. De Marzo and Elizabeth A. Platz
Bora Gurel
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
M. Scott Lucia
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Ian M. Thompson Jr
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Phyllis J. Goodman
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Catherine M. Tangen
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Alan R. Kristal
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Howard L. Parnes
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Ashraful Hoque
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Scott M. Lippman
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Siobhan Sutcliffe
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Sarah B. Peskoe
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Charles G. Drake
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
William G. Nelson
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Angelo M. De Marzo
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Elizabeth A. Platz
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
DOI: 10.1158/1055-9965.EPI-13-1126 Published May 2014

Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 23, Issue 5, pp. 847-856
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 30, 2013
- Revision received January 31, 2014
- Accepted February 17, 2014
- Published first April 18, 2014.
Article Versions
- Previous version (April 18, 2014 - 00:05).
- You are viewing the most recent version of this article.
Copyright & Usage
©2014 American Association for Cancer Research.
Author Information
- Bora Gurel1,
- M. Scott Lucia7,
- Ian M. Thompson Jr8,
- Phyllis J. Goodman10,
- Catherine M. Tangen10,
- Alan R. Kristal11,
- Howard L. Parnes6,
- Ashraful Hoque9,
- Scott M. Lippman12,
- Siobhan Sutcliffe13,
- Sarah B. Peskoe4,
- Charles G. Drake2,3,5,
- William G. Nelson1,3,5,
- Angelo M. De Marzo1,3,5, and
- Elizabeth A. Platz3,4,5
- Authors' Affiliations: Departments of 1Pathology and 2Immunology; 3The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; 6Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 7University of Colorado School of Medicine, Aurora, Colorado; 8Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; 9Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; 10SWOG Statistical Center; 11Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 12Moores Cancer Center, University of California San Diego, La Jolla, California; and 13Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
- Corresponding Authors:
Elizabeth A. Platz, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Room E6132, 615 North Wolfe Street, Baltimore, MD 21205. Phone: 410-614-9674; Fax: 410-614-2632; E-mail: eplatz{at}jhsph.edu; and Angelo M. De Marzo, Department of Pathology, Johns Hopkins School of Medicine, 1650 Orleans Street, Baltimore, MD 21231. Phone: 410-614-5686; ademarz{at}jhmi.edu
May 2014
Volume 23, Issue 5
Volume 23, Issue 5
Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
Bora Gurel, M. Scott Lucia, Ian M. Thompson Jr, Phyllis J. Goodman, Catherine M. Tangen, Alan R. Kristal, Howard L. Parnes, Ashraful Hoque, Scott M. Lippman, Siobhan Sutcliffe, Sarah B. Peskoe, Charles G. Drake, William G. Nelson, Angelo M. De Marzo and Elizabeth A. Platz
Cancer Epidemiol Biomarkers Prev May 1 2014 (23) (5) 847-856; DOI: 10.1158/1055-9965.EPI-13-1126
Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
Bora Gurel, M. Scott Lucia, Ian M. Thompson Jr, Phyllis J. Goodman, Catherine M. Tangen, Alan R. Kristal, Howard L. Parnes, Ashraful Hoque, Scott M. Lippman, Siobhan Sutcliffe, Sarah B. Peskoe, Charles G. Drake, William G. Nelson, Angelo M. De Marzo and Elizabeth A. Platz
Cancer Epidemiol Biomarkers Prev May 1 2014 (23) (5) 847-856; DOI: 10.1158/1055-9965.EPI-13-1126
Jump to section
Advertisement